Abpro Holdings (ABPO) Accounts Payables (2023 - 2026)
Abpro Holdings' (ABPO) quarterly Accounts Payables came in at $5.0 million in Q1 2026, up 5.27% YoY from $4.7 million in Q1 2025, and down 6.97% on a QoQ basis from $5.3 million in Q4 2025.
Abpro Holdings (ABPO) Accounts Payables (2023 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 4 years of Accounts Payables data on file, last reported at $5.0 million in Q1 2026.
- Quarterly Accounts Payables rose 5.27% year-over-year to $5.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 5.27% YoY) and the FY2025 annual result came in at $5.3 million, up 35.24% from the prior year.
- Accounts Payables eased to $5.0 million in Q1 2026, from $5.3 million in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $7.9 million in Q4 2023 to a low of $1.4 million in Q1 2024.
- A 4-year average of $4.1 million and a median of $4.7 million in 2025 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2024 — Accounts Payables plunged 50.28% — and 2025, when it surged 247.4%.
- Tracing ABPO's Accounts Payables over 4 years: stood at $7.9 million in 2023, then sank by 50.28% to $3.9 million in 2024, then surged by 35.24% to $5.3 million in 2025, then retreated by 6.97% to $5.0 million in 2026.
- The last three Accounts Payables figures came in at $5.0 million (Q1 2026), $5.3 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | 4.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.95 Mn |
| Dec 31, 2025 | 5.32 Mn |
| Sep 30, 2025 | 4.72 Mn |
| Jun 30, 2025 | 5.27 Mn |
| Mar 31, 2025 | 4.70 Mn |
| Dec 31, 2024 | 3.94 Mn |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 1.52 Mn |
| Mar 31, 2024 | 1.36 Mn |
| Dec 31, 2023 | 7.92 Mn |